Institutional Repository
Technical University of Crete
EN  |  EL

Search

Browse

My Space

A 21-hub-gene signature in multiple sclerosis identified using machine learning techniques

Tsakaneli Stavroula, Bei Aikaterini, Zervakis Michail

Simple record


URIhttp://purl.tuc.gr/dl/dias/1DCC5A2B-CCD5-4B80-8E61-12EF753DDEA1-
Identifierhttps://doi.org/10.1109/BHI56158.2022.9926949-
Identifierhttps://ieeexplore.ieee.org/document/9926949-
Languageen-
Extent5 pagesen
TitleA 21-hub-gene signature in multiple sclerosis identified using machine learning techniquesen
CreatorTsakaneli Stavroulaen
CreatorΤσακανελη Σταυρουλαel
CreatorBei Aikaterinien
CreatorΜπεη Αικατερινηel
CreatorZervakis Michailen
CreatorΖερβακης Μιχαηλel
PublisherInstitute of Electrical and Electronics Engineersen
Content SummaryMultiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects approximately 2.8 million persons globally. While there is currently no cure for this neurodegenerative disease, MS has become a highly manageable disease through treatment options like disease-modifying medications, that can help to control the symptoms and slow disease progression. Among them, interferon beta (IFNβ) therapy is a first-line treatment for MS but has shown to be only partially effective. Thus, it is important to identify biomarkers that aid in early identification of IFNβ responders. In this study, based on gene expression profiles from untreated and interferon treated patients from a publicly available dataset, we performed differential expression analysis and Pigengene network association (weighted correlation network analysis (WGCNA) and Bayesian networks modeling) in order to construct a high-confidence protein-protein (PPI) interaction network. Subsequently, aiming to find the most significant clustering modules and hub genes, we applied a number of topological analysis methods (cytoHubba plugin) followed by MCODE clustering algorithm. Our approach resulted in highly connected hub genes generating a reliable 21-hubgene signature that could predict the response of interferon beta (IFNβ) therapy in patients with MS. The 21-hub-gene signature showed high classification performance (Accuracy = 91,49%, Sensitivity = 94.55%, Specificity = 87.15%) demonstrating potential clinical benefit.en
Type of ItemΠλήρης Δημοσίευση σε Συνέδριοel
Type of ItemConference Full Paperen
Licensehttp://creativecommons.org/licenses/by/4.0/en
Date of Item2024-08-02-
Date of Publication2022-
SubjectDifferentially expressed genes (DEGs)en
SubjectLIMMAen
SubjectSAMen
SubjectWeighted correlation network analysis (WGCNA)en
SubjectBayesian networksen
SubjectPigengeneen
SubjectcytoHubbaen
SubjectMCODEen
SubjectInterferon beta (INFβ)en
SubjectMultiple sclerosis (MS)en
Bibliographic CitationS. Tsakaneli, E. S. Bei and M. E. Zervakis, "A 21-hub-gene signature in multiple sclerosis identified using machine learning techniques," in Proceedings of the 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI 2022), Ioannina, Greece, 2022, doi: 10.1109/BHI56158.2022.9926949.en

Services

Statistics